Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

Kidney International

Volumn 56, Issue 6, 1999, Pages 2214-2219

  Culleton, Bruce F ^a,b,c   Larson, Martin G ^a,b,c   Wilson, Peter W F ^a,b,c   Evans, Jane C ^a,b,c   Parfrey, Patrick S ^a,b,c   Levy, Daniel ^a,b,c  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Framingham Heart Study; Mortality; Renal failure; Serum creatinine

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL;

EID: 0033428802     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00773.x     Document Type: Article

References (29)

1. 1. U.S. Renal Data System: USRDS 1998 Annual Data Report. Bethesda, National Institutes of Health National Institute of Diabetes, Digestive, Kidney Diseases, 1998
2. 2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(Suppl 3):112-119, 1998
3. 3. Luke RG: Chronic renal failure: A vasculopathic state. (editorial) N Engl J Med 339:841-843, 1998
4. 4. Kasiske BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84:985-992, 1988
5. 5. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32:853-905, 1998
6. 6. Becker BN, Himmelfarb J, Henrich WL, Hakim RM: Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 8:475-486, 1997
7. 7. Venkatesan J, Henrich WL: Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Semin Nephrol 17:257-269, 1997
8. 8. Culleton BF, Wilson PWF: Thrombogenic risk factors for cardiovascular disease in dialysis patients. Semin Dial 12:117-125, 1999
9. 9. Dawber TR, Meadors GF, Moore FE: Epidemiologic approaches to heart disease: The Framingham Heart Study. Am J Public Health 41:279-286, 1951
10. 10. Gordon T, Moore FEJ, Shurtleff D, Dawber TR: Some methodologic problems in the long-term study of cardiovascular disease: Observations on the Framingham Study. J Chronic Dis 10:186-206, 1959
11. 11. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families: The Framingham Offspring Study. Am J Epidemiol 110:281-290, 1979
12. 12. Anonymous: The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413-2446, 1997
13. 13. Bowers LD, Wong ET: Kinetic serum creatinine assays. II. A critical evaluation and review. Clin Chem 26:555-561, 1980
14. 14. Bowers LD: Kinetic serum creatinine assays. I. The role of various factors in determining specificity. Clin Chem 26:551-554, 1980
15. 15. Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 38:1933-1953, 1992
16. 16. Abell LL, Levy BB, Brodie: BB, Kendall FE: A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195:357-366, 1952
17. 17. Culleton BF, Larson MG, Evans JC, Wilson PWF, Barrett BJ, Parfrey PS, Levy D: Prevalence and correlates of elevated serum creatinine: The Framingham Heart Study. Arch Intern Med 159:1785-1790, 1999
18. 18. Shurtleff D: Some characteristics related to the incidence of cardiovascular disease and death: Framingham Heart Study 18-year follow-up, in The Framingham Study (section 30), edited by Kannel WB, Gordon T, Washington D.C., U.S. Government Printing Office, 1974, pp 17-25
19. 19. Cox DR: Regression models and life tables (with discussion). J R Stat Soc 34:187-220, 1972
20. 20. SAS Institute Inc: SAS/STAT Software: Changes and Enhancements Through Release 6.11. Cary, 1996
21. 21. Jungers P, Massy A, Nguyen Khoa T, Fumeron M, Labrunie M, Lacour B, Descamps-Latscha B, Man NK: Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 12:2597-2602, 1997
22. 22. Wannamethee SG, Shaper AG, Perry IJ: Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. Stroke 28:557-563, 1997
23. 23. Matts JP, Karnegis JN, Campos CT, Fitch LL, Johnson JW, Buchwald H: Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. J Fam Pract 36:497-503, 1993
24. 24. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the hypertension detection and follow-up program. Hypertension 13:180-193, 1989
25. 25. Friedman PJ: Serum creatinine: An independent predictor of survival after stroke. J Intern Med 229:175-179, 1991
26. 26. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, Gardin JM: Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 279:585-592, 1998
27. 27. U.S. Renal Data System: USRDS 1997 Annual Data Report. Bethesda, National Institutes of Health National Institute of Diabetes, Digestive, Kidney Diseases, 1997
28. 28. Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 39:465-490, 1988
29. 29. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976